Janux Therapeutics (JANX) News Today $22.72 -0.19 (-0.83%) Closing price 04:00 PM EasternExtended Trading$22.75 +0.03 (+0.13%) As of 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock JANX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Janux Therapeutics (NASDAQ:JANX) Stock Price Down 3.6% - Should You Sell?Janux Therapeutics (NASDAQ:JANX) Trading Down 3.6% - Should You Sell?June 16 at 4:45 PM | marketbeat.comCantor Fitzgerald Weighs in on JANX FY2026 EarningsJune 12, 2025 | americanbankingnews.comResearch Analysts Offer Predictions for JANX FY2026 EarningsJanux Therapeutics, Inc. (NASDAQ:JANX - Free Report) - Cantor Fitzgerald issued their FY2026 EPS estimates for Janux Therapeutics in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer anticipates that the company will earn ($4.43) per share for the year. The conseJune 10, 2025 | marketbeat.comCalifornia State Teachers Retirement System Grows Stock Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX)California State Teachers Retirement System lifted its position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 82.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,7June 8, 2025 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Shares Up 7.9% - Here's What HappenedJanux Therapeutics (NASDAQ:JANX) Stock Price Up 7.9% - Here's WhyJune 6, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Sees Significant Increase in Short InterestJanux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 11,550,000 shares, a growth of 19.7% from the April 30th total of 9,650,000 shares. Approximately 23.3% of the company's stock are short sold. Based on an average daily volume of 1,010,000 shares, the days-to-cover ratio is currently 11.4 days.June 5, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Takes $2.48 Million Position in Janux Therapeutics, Inc. (NASDAQ:JANX)Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 46,264 shares ofJune 3, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Wellington Management Group LLPWellington Management Group LLP increased its stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 3,592.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 535,396 shares oJune 1, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 532.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fiJune 1, 2025 | marketbeat.comTwo Sigma Investments LP Lowers Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)Two Sigma Investments LP lessened its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 22.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 59,974 shares of the company's stoMay 31, 2025 | marketbeat.comNuveen Asset Management LLC Sells 39,145 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Nuveen Asset Management LLC decreased its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 23.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 127,747 shares of the comMay 31, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Purchased by Squarepoint Ops LLCSquarepoint Ops LLC grew its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 155.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 41,176 shares of the company's sMay 30, 2025 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Stock Price Down 4.2% - Should You Sell?Janux Therapeutics (NASDAQ:JANX) Trading Down 4.2% - Here's WhyMay 29, 2025 | marketbeat.comMillennium Management LLC Invests $6.22 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)Millennium Management LLC purchased a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 116,102 shares of the company's stMay 29, 2025 | marketbeat.comNationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Has $22.99 Million Stock Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX)Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. lessened its stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 9.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 429,392 shares of the company'sMay 22, 2025 | marketbeat.comWoodline Partners LP Buys 251,924 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Woodline Partners LP grew its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 15.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,852,187 shares of the company's stock after acquiring an additionaMay 22, 2025 | marketbeat.comRafferty Asset Management LLC Sells 13,522 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Rafferty Asset Management LLC decreased its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 20.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 52,168 shares of the company's stock after selling 13,522 shares during the period. RMay 22, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Given Average Rating of "Buy" by AnalystsJanux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) has earned an average rating of "Buy" from the eleven brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, eight have assigned a buy recommendation and twoMay 22, 2025 | marketbeat.comDeutsche Bank AG Purchases 73,912 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Deutsche Bank AG boosted its position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 386.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 93,029 shares of the company's stock after buying an additional 73,9May 21, 2025 | marketbeat.comTroluce Capital Advisors LLC Buys New Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)Troluce Capital Advisors LLC bought a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 32,297 shares of the company's stMay 20, 2025 | marketbeat.com50,000 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Purchased by Tang Capital Management LLCTang Capital Management LLC purchased a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 50,000 shares of the company's stock, valued at approMay 20, 2025 | marketbeat.comPoint72 Asset Management L.P. Boosts Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX)Point72 Asset Management L.P. boosted its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 57.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 621,383 shares of the company's stock after buyingMay 19, 2025 | marketbeat.comSphera Funds Management LTD. Takes Position in Janux Therapeutics, Inc. (NASDAQ:JANX)Sphera Funds Management LTD. bought a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 68,333 shares of the company's stocMay 18, 2025 | marketbeat.comLazard Asset Management LLC Buys New Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)Lazard Asset Management LLC purchased a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 82,005 shares of the company's stock, valued at approximMay 18, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) is Prosight Management LP's 10th Largest PositionProsight Management LP increased its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 60.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 329,768 shares of the company's stock after purchasing an additional 1May 17, 2025 | marketbeat.comBank of America Corp DE Purchases 731,962 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Bank of America Corp DE grew its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 1,165.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 794,761 shares of the company's stock after purchasingMay 17, 2025 | marketbeat.comNorthern Trust Corp Buys 42,302 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Northern Trust Corp boosted its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 15.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 308,800 shares of the company's stock afteMay 17, 2025 | marketbeat.comMPM Bioimpact LLC Raises Stake in Janux Therapeutics, Inc. (NASDAQ:JANX)MPM Bioimpact LLC boosted its holdings in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 34.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 230,000 shares of the company's stock after acquiring anMay 16, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) is Paradigm Biocapital Advisors LP's 5th Largest PositionParadigm Biocapital Advisors LP boosted its holdings in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 46.5% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,515,986 shares of the company's stock after acquirMay 16, 2025 | marketbeat.comNicholas Investment Partners LP Invests $2.73 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)Nicholas Investment Partners LP bought a new position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 50,958 shares of the company's stock, valued aMay 16, 2025 | marketbeat.comResearch Analysts Offer Predictions for JANX FY2025 EarningsJanux Therapeutics, Inc. (NASDAQ:JANX - Free Report) - Cantor Fitzgerald boosted their FY2025 earnings estimates for shares of Janux Therapeutics in a report issued on Monday, May 12th. Cantor Fitzgerald analyst J. Schimmer now expects that the company will post earnings per share of ($3.28) forMay 16, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Outlook for JANX EarningsJanux Therapeutics, Inc. (NASDAQ:JANX - Free Report) - Equities researchers at Leerink Partnrs lifted their Q2 2025 earnings per share (EPS) estimates for Janux Therapeutics in a note issued to investors on Monday, May 12th. Leerink Partnrs analyst J. La. Rosa now forecasts that the company willMay 16, 2025 | marketbeat.comJanux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development OfficerMay 15, 2025 | finance.yahoo.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Sold by Orbimed Advisors LLCOrbimed Advisors LLC reduced its position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 39.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 758,566 shares of the company's stock after sellingMay 15, 2025 | marketbeat.comIntegral Health Asset Management LLC Invests $10.71 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)Integral Health Asset Management LLC acquired a new position in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 200,000 shares of the company's stock, valued at approximately $10,708,May 14, 2025 | marketbeat.comJanux Therapeutics, Inc. (NASDAQ:JANX) Shares Acquired by Janus Henderson Group PLCJanus Henderson Group PLC boosted its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 41.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,562,402 shares of the company's stMay 14, 2025 | marketbeat.com40,349 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Purchased by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC bought a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 40,349 shares of the company's stockMay 14, 2025 | marketbeat.com23,501 Shares in Janux Therapeutics, Inc. (NASDAQ:JANX) Purchased by Fred Alger Management LLCFred Alger Management LLC acquired a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 23,501 shares of the company's stock, valued at approximately $1,258May 13, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Purchases 32,917 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)The Manufacturers Life Insurance Company raised its holdings in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 107.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 63,512 shares of the company'May 12, 2025 | marketbeat.comFarallon Capital Management LLC Acquires Shares of 48,000 Janux Therapeutics, Inc. (NASDAQ:JANX)Farallon Capital Management LLC acquired a new stake in Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 48,000 shares of the company's stock, valueMay 11, 2025 | marketbeat.comDriehaus Capital Management LLC Invests $27.61 Million in Janux Therapeutics, Inc. (NASDAQ:JANX)Driehaus Capital Management LLC bought a new stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 515,646 shares of the company's stock, valued at approxiMay 11, 2025 | marketbeat.comCrestline Management LP Acquires New Position in Janux Therapeutics, Inc. (NASDAQ:JANX)Crestline Management LP bought a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 23,414 shares of the company's stock, valued atMay 11, 2025 | marketbeat.comAlgert Global LLC Acquires 40,489 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Algert Global LLC boosted its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 165.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 64,961 shares of the company's stock after buying an additional 40,489 shares during the perioMay 9, 2025 | marketbeat.comJanux Therapeutics Reports First Quarter 2025 Financial Results and Business HighlightsMay 8, 2025 | businesswire.comCutter Capital Management LP Makes New $6.43 Million Investment in Janux Therapeutics, Inc. (NASDAQ:JANX)Cutter Capital Management LP acquired a new position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 120,000 shares of the company's stock, valMay 8, 2025 | marketbeat.comJanux Therapeutics (NASDAQ:JANX) Shares Gap Down on Insider SellingJanux Therapeutics (NASDAQ:JANX) Shares Gap Down Following Insider SellingMay 7, 2025 | marketbeat.comAlyeska Investment Group L.P. Raises Stock Holdings in Janux Therapeutics, Inc. (NASDAQ:JANX)Alyeska Investment Group L.P. grew its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 69.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 344,916 shares of the company's stoMay 7, 2025 | marketbeat.comJanux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside PotentialMay 6, 2025 | finance.yahoo.comJanux Therapeutics begins phase 1b trial for prostate cancer therapyMay 6, 2025 | investing.comAvidity Partners Management LP Purchases 179,900 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)Avidity Partners Management LP lifted its stake in shares of Janux Therapeutics, Inc. (NASDAQ:JANX - Free Report) by 32.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 741,900 shares of the company's stock after purchMay 6, 2025 | marketbeat.com Get Janux Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter. Email Address JANX Media Mentions By Week JANX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JANX News Sentiment▼0.810.56▲Average Medical News Sentiment JANX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JANX Articles This Week▼35▲JANX Articles Average Week Get Janux Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JANX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GRFS News Today LNTH News Today TLX News Today NUVL News Today AXSM News Today ADMA News Today PCVX News Today AKRO News Today RYTM News Today ZLAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JANX) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Janux Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Janux Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy JANX Stock Free JANX Stock Alerts